Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02646579 · ClinicalTrials.gov registry record · NA

Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only

A NA study, sponsored by Emory University.

Completed
Registry status
NA
Development phase
34
Enrollment target

NCT02646579: Completed NA study, sponsored by Emory University.

NCT02646579 is a NA study that has completed, run by Emory University. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02646579, a NA study, has completed, sponsored by Emory University.

COMPLETED
Registry status
NA
Development phase
34 participants
Enrollment target

Study Summary

The purpose of this study is to determine if dry needling both low back and extremity areas is more effective for reducing pain and improving strength, balance and functional performance among patients with chronic musculoskeletal conditions compared to dry needling of extremity areas only.

Primary Outcome

Pain level will be assessed using the Visual Analogue Scale (VAS). The pain VAS is a self-reported, single-item scale that ranks pain level from no pain to worst imaginable pain on a single scale line. Using a ruler, the score is determined by measuring the distance (mm) on the 10-cm line between the "no pain" anchor and the participant's mark, providing a range of scores from 0-100.

Interventions

  • PROCEDURE Spinal and Peripheral Dry Needling
  • PROCEDURE Peripheral Dry Needling

Trial Details

FieldValue
Enrollment Target 34 participants
Start Date 2017-10-27
Est. Completion 2019-05-01
Phase NA
Emory University

1,208 total trials

What the finished NCT02646579 record still lists

NCT02646579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Spinal and Peripheral Dry Needling is the first listed.

NCT02646579 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02646579 about?

NCT02646579 is a clinical study titled "Effects of Dry Needling Using Spinal and Peripheral Sites Versus Peripheral Sites Only". The purpose of this study is to determine if dry needling both low back and extremity areas is more effective for reducing pain and improving strength, balance and functional performance among patients with chronic musculoskeletal conditions compared to dry needling of extremity areas only.

What is the current status of trial NCT02646579?

This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2017-10-27. Estimated completion is 2019-05-01.

What interventions are being tested in trial NCT02646579?

The interventions under investigation include: Spinal and Peripheral Dry Needling (PROCEDURE), Peripheral Dry Needling (PROCEDURE).

Who is sponsoring clinical trial NCT02646579?

This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02646579's enrollment target sits among peer trials

34 1570th of 2000 higher than 427 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02897063 · 34 participants · Phase 1

    Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure

  • NCT03906617 · 34 participants · Phase 4

    Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine

  • NCT03992378 · 34 participants · NA

    Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis

  • NCT04047849 · 34 participants · Phase 4

    Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT02646579, the US trial registry maintained by the National Library of Medicine. NCT02646579 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.